$0.27
▼ -14.6% Today
as of Oct 22, 16:51 ET
Last 30 days
Recent Press Releases & News
CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
PPCB earnings at a glance
Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±10.7% on average; after the most recent report on May 14, 2026 it moved -21.4%. The share price of $0.27 sits near its 52-week low.
Overview
52-week range
$0.27
$38
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-10.7%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.28 | — | — | +97.8% | -21.4% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $-0.30 | — | — | — | — | financials |
| Fri Nov 14, 2025 | Sep/2025 | $-0.39 | — | — | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-12.50 | — | — | — | 0.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-35.97 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-545.79 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-1559.55 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.04 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.53 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $-2.13 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-6M | $-4M | $-5M | — | — | — | $-290,790 | — |
| Net income | $-6M | $-3M | — | — | — | — | — | — |
| EPS (diluted) | $-0.28 | $-0.30 | $-0.39 | — | — | — | $-35.97 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | $602,737 | — | $50,760 | $14,633 | $9,268 | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $8M | $8M | $9M | $8M | $10M | $17,984 | $21,534 | $25,441 |
| Total assets | $14M | $15M | $18M | $20M | $23M | $78,533 | $63,644 | $72,365 |
| Long-term debt | $55,000 | $55,000 | $106,968 | $537,921 | $438,578 | $409,799 | $381,789 | $399,325 |
| Total liabilities | $4M | $4M | $4M | $6M | $4M | $4M | $4M | $4M |
| Total equity | $10M | $10M | — | $14M | — | — | — | $-4M |
Implied volatility — last 90 days
No IV snapshots yet for PPCB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
PPCB earnings FAQ
How does PPCB stock usually react to earnings?
Across the last 2 reports the average next-day move was ±10.7%, up 0 times and down 2 times.